Research ExplorerScientific StaffMartin Lambert Publications

Prof. Dr. med. ID: 57412

Martin Lambert

Group leader

graph of relations
Affiliations
Emails
Phone: 0049-40-7410-24041Fax: 0049-40-7410-52999
1 - 50 out of 496Page size: 50

Publications

  1. 1997

  2. [Consumption patterns and motivation for use of addictive drugs in schizophrenic patients]

    Lambert, M., Haasen, C., Mass, R. & Krausz, M., 1997, In: PSYCHIAT PRAX. 24, 4, p. 185-189 4.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  3. Diagnostic aspects of psychiatric disorders among migrants.

    Haasen, C., Lambert, M. & Yagdiran, O., 1997, In: Curare. 19, p. 347-352

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  4. Influence of addictive behaviour on psychopathology in paranoid schizophrenia.

    Krausz, M., Lambert, M., Haasen, C. & Mac, R., 1997, In: Krankenhauspsychiatrie. 8, p. 104-110

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  5. Psychiatric disorders among migrants in Germany: prevalence in a psychiatric clinic and implications for services and research.

    Haasen, C., Lambert, M., Yagdiran, O. & Krausz, M., 1997, In: EUR PSYCHIAT. 12, p. 305-310

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  6. Konsummuster und Konsummotivation des Suchtmittelgebrauchs bei schizophrenen Patienten

    Lambert, M., Haasen, C., Mass, R. & Krausz, M., 07.1997, In: PSYCHIAT PRAX. 24, 4, p. 185-9 5 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  7. 1998

  8. Differential diagnosis of psychotic disorders in immigrants.

    Lambert, M., Haasen, C. & Halilovic, H., 1998, In: PSYCHIAT PRAX. 25, p. 198-9

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  9. Impact of ethnicity on the prevalence of psychiatric disorders among migrants in Germany.

    Haasen, C., Lambert, M., Mass, R. & Krausz, M., 1998, In: ETHNIC HEALTH. 3, 3, p. 159-165 3.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  10. Psychotic disorders in migrants: empirical results and case-reports.

    Yagdiran, O., Haasen, C., Lambert, M., Schröder, J. & Krausz, M., 1998, In: Psycho. 25, p. 198-9

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  11. 1999

  12. [Admission status of alcohol and drug-dependent patients in "high threshold" access to withdrawal treatment]

    Wagner, H. B., Schwoon, D., Lambert, M. & Krausz, M., 1999, In: PSYCHIAT PRAX. 26, 1, p. 25-28 1.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  13. Amisulpride - an atypical antipsychotic in the treatment of schizophrenia.

    Lambert, M. & Naber, D., 1999, In: Fundamenta Psychiatrica. 13, p. 43-70

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  14. Atypical Antipsychotics: compliance and quality of life.

    Naber, D. & Lambert, M., 1999, Atypical antipsychotics in the treatment of schizophrenic patients. Möller, HJ. & Müller, N. (eds.). Steinkopff-Publisher, p. 1-16

    Research output: SCORING: Contribution to book/anthology › SCORING: Contribution to collected editions/anthologies › Research › peer-review

  15. Atypical neuroleptics - a new area in the treatment of schizophrenic patients?

    Lambert, M., 1999, In: Psychosoziale Umschau. 1, p. 28-29

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  16. Atypical neuroleptics in the treatment of schizophrenic patients.

    Naber, D., Lambert, M. & Krausz, M., 1999, Uni-Med. 178 p.

    Research output: Book/anthology › Collected edition/anthology › Research

  17. Cannabis.

    Krausz, M. & Lambert, M., 1999, Addiction medicine - concepts, strategies and therapeutical interventions. Uchtenhagen, A. & Ziegelgänsberger, G. (eds.). Urban & Fischer, p. 77-82

    Research output: SCORING: Contribution to book/anthology › SCORING: Contribution to collected editions/anthologies › Research › peer-review

  18. Consequences of language problems in inpatients Treatment of immigrants.

    Haasen, C., Kraft, M., Yagdiran, O., Maß, R., Lambert, M., Müller-Thomsen, T. & Krausz, M., 1999, In: Krankenhauspsychiatrie. 10, p. 91-95

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  19. Could atypical antipsychotics improve rehabilitation of schizophrenic patients?

    Perro, C., Lambert, M. & Naber, D., 1999, In: Gfts-Journal. 14, p. 18-22

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  20. Language effect on assessment of psychopathology.

    Haasen, C., Yagdiran, O., Lambert, M. & Krausz, M., 1999, In: CURR OPIN PSYCHIATR. 12, p. 11-24

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  21. Langzeitbehandlung der Schizophrenie.

    Lambert, M., 1999, Atypische Neuroleptika in der Behandlung schizophrener Patienten. Naber, D., Lambert, M. & Krausz, M. (eds.). Uni-Med, p. 71-75

    Research output: SCORING: Contribution to book/anthology › SCORING: Contribution to collected editions/anthologies › Research › peer-review

  22. Neurocognitive alterations in the treatment of schizophrenic patients with clozapine.

    Moritz, S., Naber, D., Krausz, M., Lambert, M. & Andresen, B., 1999, Clozapine - pharmacology and clinical issues of an atypical antipsychotic. Naber, D. & Müller-Spahn, F. (eds.). Berlin Heidelberg New York: Springer, p. 90-108

    Research output: SCORING: Contribution to book/anthology › SCORING: Contribution to collected editions/anthologies › Research › peer-review

  23. Neuroleptic-induced extrapyramidal symptoms are accompanied by cognitive dysfunction in schizophrenia.

    Krausz, M., Moritz, S., Naber, D., Lambert, M. & Andresen, B., 1999, In: EUR PSYCHIAT. 14, 2, p. 84-88 2.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  24. Neuroleptische Nebenwirkungen und deren Behandlung.

    Lambert, M., 1999, Atypische Neuroleptika in der Behandlung schizophrener Patienten. Naber, D., Lambert, M. & Krausz, M. (eds.). Uni-Med, p. 54-68

    Research output: SCORING: Contribution to book/anthology › SCORING: Contribution to collected editions/anthologies › Research › peer-review

  25. Nichtpharmakologische Behandlungsansätze in der Schizophrenietherapie.

    Lambert, M., 1999, Atypische Neuroleptika in der Behandlung schizophrener Patienten. Naber, D., Lambert, M. & Krausz, M. (eds.). Uni-Med, p. 98-120

    Research output: SCORING: Contribution to book/anthology › SCORING: Contribution to collected editions/anthologies › Research › peer-review

  26. Olanzapine - an atypical antipsychotic in the treatment of schizophrenia.

    Lambert, M., Perro, C., Holzbach, R., Krausz, M. & Naber, D., 1999, In: PSYCHOPHARMAKOTHERAP. 2, p. 38-52

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  27. Optimising treatment of schizophrenic patients with atypical neuroleptics.

    Lambert, M., Moritz, S. & Naber, D., 1999, In: PSYCHOPHARMAKOTHERAP. 3, p. 42-54

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  28. Pharmacotherapy of schizophrenia spectrum disorders in a dayclinicl setting.

    Lambert, M., Stark, M., Krausz, M. & Naber, D., 1999, Dayclinical treatment. Eikelmann, B. (ed.). Georg Thieme Verlag KG, p. 83-96

    Research output: SCORING: Contribution to book/anthology › SCORING: Contribution to collected editions/anthologies › Research › peer-review

  29. Pharmacotherapy of schizophrenia spectrum disorders - the actual state.

    Lambert, M., Haasen, C. & Naber, D., 1999, Schizophrenia - ways of treatment. Hartwich, P. & Pflug, B. (eds.). Publisher Wissenschaft & Praxis, p. 95-122

    Research output: SCORING: Contribution to book/anthology › SCORING: Contribution to collected editions/anthologies › Research › peer-review

  30. Pharmakokinetik atypischer Neuroleptika.

    Lambert, M., 1999, Atypische Neuroleptika in der Behandlung schizophrener Patienten. Naber, D., Lambert, M. & Krausz, M. (eds.). Uni-Med, p. 30-36

    Research output: SCORING: Contribution to book/anthology › SCORING: Contribution to collected editions/anthologies › Research › peer-review

  31. Pharmakologie atypischer Neuroleptika.

    Lambert, M., 1999, Atypische Neuroleptika in der Behandlung schizophrener Patienten. Naber, D., Lambert, M. & Krausz, M. (eds.). Uni-Med, p. 18-27

    Research output: SCORING: Contribution to book/anthology › SCORING: Contribution to collected editions/anthologies › Research › peer-review

  32. Pharmakotherapie ersterkrankter schizophrener Patienten.

    Lambert, M., 1999, Atypische Neuroleptika in der Behandlung schizophrener Patienten. Naber, D., Lambert, M. & Krausz, M. (eds.). Uni-Med, p. 69-71

    Research output: SCORING: Contribution to book/anthology › SCORING: Contribution to collected editions/anthologies › Research › peer-review

  33. Psychiatric disorders of immigrants in the clinical setting.

    Lambert, M., Haasen, C., Yagdiran, O. & Krausz, M., 1999, In: Krankenhauspsychiatrie. 2, p. 49-53

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  34. Psychological disorders as risk factor for addictive behaviour.

    Krausz, M. & Lambert, M., 1999, Addiction medicine - concepts, strategies and therapeutical interventions. Uchtenhagen, A. & Ziegelgänsberger, G. (eds.). Urban & Fischer, p. 206-211

    Research output: SCORING: Contribution to book/anthology › SCORING: Contribution to collected editions/anthologies › Research › peer-review

  35. Psychopharmacological treatment of the first acute schizophrenic episode schould consist of atypical neuroleptics.

    Naber, D., Krausz, M. & Lambert, M., 1999, In: Belgian Consensus Conference on the Treatment of Schizophrenia. 12, p. 76-94

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  36. Psychopharmakotherapie der akuten Schizophrenie.

    Lambert, M., 1999, Atypische Neuroleptika in der Behandlung schizophrener Patienten. Naber, D., Lambert, M. & Krausz, M. (eds.). Uni-Med, p. 41-50

    Research output: SCORING: Contribution to book/anthology › SCORING: Contribution to collected editions/anthologies › Research › peer-review

  37. [Quality of life. Construct validation and the development of a modular system]

    Pukrop, R., Möller, H. J., Sass, H., Sauer, H., Klosterkötter, J., Czernik, A., Krausz, M., Stieglitz, R. D., Lambert, M., Matthies, H., Schaub, A., Woschnik, M., Wulfinghoff, F. & Steinmeyer, E. M., 1999, In: NERVENARZT. 70, 1, p. 41-53 1.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  38. Refractory Schizophrenia.

    Naber, D., Krausz, M., Lambert, M. & Bender, S., 1999, Difficult clinical problems in psychiatry. Lader, M. & Naber, D. (eds.). Martin Dunitz Publishers, p. 3-22

    Research output: SCORING: Contribution to book/anthology › SCORING: Contribution to collected editions/anthologies › Research › peer-review

  39. Reviews der atypischen Neuroleptika Zotepin, Risperidon, Olanzapin, Clozapin, Sertindol, Quetiapin, Ziprasidon und Amisulprid.

    Lambert, M., 1999, Atypische Neuroleptika in der Behandlung schizophrener Patienten. Naber, D., Lambert, M. & Krausz, M. (eds.). Uni-Med, p. 121-177

    Research output: SCORING: Contribution to book/anthology › SCORING: Contribution to collected editions/anthologies › Research › peer-review

  40. Sertindole decreases hospitalisation and improves the quality of life of schizophrenic patients.

    Naber, D. & Lambert, M., 1999, In: INT J PSYCHIAT CLIN. 2, p. 73-77

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  41. Spezielle Aspekte der Langzeitbehandlung.

    Lambert, M., 1999, Atypische Neuroleptika in der Behandlung schizophrener Patienten. Naber, D., Lambert, M. & Krausz, M. (eds.). Uni-Med, p. 78-97

    Research output: SCORING: Contribution to book/anthology › SCORING: Contribution to collected editions/anthologies › Research › peer-review

  42. Stimulus onset asynchronicity as a Modulator of negative priming in schizotypy.

    Moritz, S., Andresen, B., Probsthein, E., Martin, T., Domin, F., Kretschmar, G., Krausz, M., Lambert, M. & Naber, D., 1999, In: PERS INDIV DIFFER. 3, p. 1-9

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  43. [Success of new treatments for schizophrenics, as shown by the example of modern antipsychotic drugs]

    Lambert, M., Naber, D., Perro, C., Moritz, S. & Krausz, M., 1999, In: PSYCHIAT PRAX. 26, 1, p. 30-35 1.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  44. Das Konstrukt Lebensqualität. Metaanalytische Validierung und die Entwicklung eines modularen Erhebungssystems

    Pukrop, R., Möller, H. J., Sass, H., Sauer, H., Klosterkötter, J., Czernik, A., Krausz, M., Stieglitz, R. D., Lambert, M., Matthies, H., Schaub, A., Woschnik, M., Wulfinghoff, F. & Steinmeyer, E. M., 01.1999, In: NERVENARZT. 70, 1, p. 41-53 13 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  45. Chancen neuer Therapien schizophrener Patienten am Beispiel moderner Antipsychotika

    Lambert, M., Naber, D., Perro, C., Moritz, S. & Krausz, M., 04.1999, In: PSYCHIAT PRAX. 26 Suppl 1, p. S30-5

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research

  46. 2000

  47. Aspects of inpatients treatment of immigrants in Hamburg.

    Haasen, C., Yagdiran, O., Lambert, M. & Krausz, M., 2000, In: Fundamenta Psychiatrica. 14, p. 18-22

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  48. Atypical neuroleptics - new perspective in the treatment of schizophrenia?

    Yagdiran, O., Lambert, M., Krausz, M. & Naber, D., 2000, In: Arzt und Krankenhaus. 4, p. 180-188

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  49. Cognitive dysfunction at baseline predicts symptomatic 1-year outcome in first-episode schizophrenics.

    Moritz, S., Krausz, M., Gottwalz, E., Lambert, M., Perro, C., Ganzer, S. & Naber, D., 2000, In: PSYCHOPATHOLOGY. 33, 1, p. 48-51 1.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  50. [Conversion from typical to atypical neuroleptics. Guidelines for ambulatory and inpatient treatment]

    Lambert, M., Moritz, S., Haasen, C. & Naber, D., 2000, In: NERVENARZT. 71, 11, p. 859-875 11.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  51. Dosage of conventional neuroleptic medication and subjective cognitive functioning in schizophrenia.

    Krausz, M., Moritz, S., Lambert, M. & Naber, D., 2000, In: INT CLIN PSYCHOPHARM. 15, 2, p. 77-81 2.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  52. Increased prevalence of schizophrenia in turkish immigrants: an indication for misdiagnosis?

    Haasen, C., Yagdiran, O., Maß, R., Lambert, M. & Krausz, M., 2000, Transcultural psychotherapy in various psychiatric institutions.. Heise, T. (ed.). VWB Berlin Publisher, p. 297-305

    Research output: SCORING: Contribution to book/anthology › SCORING: Contribution to collected editions/anthologies › Research › peer-review

  53. PERSIST - Personenzentrierte Settingübergreifende Integrative Schizophrenietherapie.

    Basdekis, R., Briken, P., Gottwalz, E., Karow, A., Nika, E., Lambert, M., Moritz, S., Perro, C., Yagdiran, O., Jung, J. & Krausz, M., 2000, In: NERVENARZT. 71, p. 137-138

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  54. PERSIST - PERsonenzentrierte Settingübergreifende Integrative Schizophrenie Therapie.

    Karow, A., Perro, C., Moritz, S., Yagdiran, O., Nika, E., Basdekis, R., Lambert, M., Briken, P., Gottwalz, E., Jung, J. & Krausz, M., 2000, Clozapine - pharmacology and clinical issues of an atypical anti-psychotic: aspects of quality of life.. Naber, D. & Müller-Spahn, F. (eds.). Berlin Heidelberg New York: Springer, p. 84-91

    Research output: SCORING: Contribution to book/anthology › SCORING: Contribution to collected editions/anthologies › Research › peer-review

Previous 1 2 3 4 5 6 7 8 ...10 Next